Bruker (BRKR) FCF Payout Ratio Growth (1y) (2016 - 2026)
Bruker (BRKR) FCF Payout Ratio Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.00% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -67.77% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.45% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -436.40% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 46.43% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Bruker | 9.46 Bn | 9.50 Bn | 379.80 Mn | -18.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.10% |
| Dec 31, 2025 | -26.99% |
| Sep 30, 2025 | -110.72% |
| Jun 30, 2025 | 84.41% |
| Mar 31, 2025 | -98.92% |
| Dec 31, 2024 | 18.17% |
| Sep 30, 2024 | 204.57% |
| Jun 30, 2024 | -1,046.81% |
| Mar 31, 2024 | 15,313.85% |
| Dec 31, 2023 | -22.39% |
| Sep 30, 2023 | -31.40% |
| Jun 30, 2023 | 76.27% |
| Mar 31, 2023 | -7.17% |
| Dec 31, 2022 | -0.72% |
| Sep 30, 2022 | -21.87% |
| Jun 30, 2022 | 98.60% |
| Mar 31, 2022 | 53.27% |
| Dec 31, 2021 | 154.82% |
| Sep 30, 2021 | 738.88% |
| Jun 30, 2021 | -556.37% |